Division of Respiratory & Critical Care Medicine, Department of Medicine, National University Health System, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Division of Critical Care - Respiratory Therapy, National University Hospital, Singapore.
Aust Crit Care. 2021 Nov;34(6):539-546. doi: 10.1016/j.aucc.2020.11.008. Epub 2021 Feb 23.
Severe patient-ventilator asynchrony (PVA) might be associated with prolonged mechanical ventilation and mortality. It is unknown if systematic screening and application of conventional methods for PVA management can modify these outcomes. We therefore constructed a twice-daily bedside PVA screening and management protocol and investigated its effect on patient outcomes.
A retrospective cohort study of patients who were intubated in the emergency department and directly admitted to the medical intensive care unit (ICU). In phase 1 (6 months; August 2016 to January 2017), patients received usual care comprising lung protective ventilation and moderate analgesia/sedation. In phase 2 (6 months; February 2017 to July 2017), patients were additionally managed with a PVA protocol on ICU admission and twice daily (7 am, 7 pm).
A total of 280 patients (160 in phase 1, 120 in phase 2) were studied (age = 64.5 ± 21.4 years, 107 women [38.2%], Acute Physiology and Chronic Health Evaluation II score = 27.1 ± 8.5, 271 [96.8%] on volume assist-control ventilation initially). Phase 2 patients had lower hospital mortality than phase 1 patients (20.0% versus 34.4%, respectively, P = 0.011), even after adjustment for age and Acute Physiology and Chronic Health Evaluation II scores (odds ratio = 0.46, 95% confidence interval = 0.25-0.84).
Application of a bedside PVA protocol for mechanically ventilated patients on ICU admission and twice daily was associated with decreased hospital mortality. There was however no association with sedation-free days or mechanical ventilation-free days through day 28 or length of hospital stay.
严重的人机不同步(PVA)可能与延长机械通气和死亡率有关。目前尚不清楚系统筛查和应用常规的 PVA 管理方法是否可以改变这些结果。因此,我们构建了一个每日两次的床边 PVA 筛查和管理方案,并研究了其对患者预后的影响。
这是一项回顾性队列研究,纳入在急诊科插管并直接转入重症监护病房(ICU)的患者。在第一阶段(6 个月;2016 年 8 月至 2017 年 1 月),患者接受常规治疗,包括肺保护性通气和适度的镇痛/镇静。在第二阶段(6 个月;2017 年 2 月至 7 月),患者在 ICU 入院时和每日两次(上午 7 点,晚上 7 点)接受 PVA 方案管理。
共纳入 280 例患者(第一阶段 160 例,第二阶段 120 例)(年龄=64.5±21.4 岁,107 例女性[38.2%],急性生理学和慢性健康评估 II 评分=27.1±8.5,初始 271 例[96.8%]为容量辅助控制通气)。与第一阶段相比,第二阶段患者的院内死亡率较低(分别为 20.0%和 34.4%,P=0.011),即使在校正年龄和急性生理学和慢性健康评估 II 评分后(比值比=0.46,95%置信区间=0.25-0.84)。
在 ICU 入院和每日两次时,对机械通气患者应用床边 PVA 方案与降低院内死亡率相关。然而,通过第 28 天或住院时间,与镇静无天数或机械通气无天数无关。